FDA Stops Recommending Covid Shots for Most Americans

Never forget what they did to us.

To many young people r suffered debilitating life long vax injuries or  died suddenly.

The COVID vaccine horror was one the worst mass scale human medical trials in history.

“We’re finally falling in line with all the other thoughtful people in the world who think it is ridiculous to give a healthy 12-year-old girl her seventh dose without any evidence.” Free Press: the government will no longer recommend Covid booster shots for healthy Americans ages 64 and younger. In addition, as of today, Covid vaccine manufacturers like Moderna and Pfizer will have to conduct trials to prove that their updated vaccines offer clinical benefits such as fewer symptoms, hospitalizations, or deaths. Previously, pharmaceutical companies only had to show that their updated booster shots produced antibodies. That less rigorous standard will still apply for people 65 and older and the immunocompromised…. Vinay Prasad: “We’re finally falling in line with all the other thoughtful people in the world who think it is ridiculous to give a healthy 12-year-old girl her seventh dose without any evidence,” Prasad said. “And we’re not saying we’re never going to do it—we’re just saying: Prove to me it helps her before we do it” (Free Press).

Vinay Prasad and Marty Makary: Moving forward, the FDA will adopt the following Covid-19 vaccination regulatory framework: On the basis of immunogenicity — proof that a vaccine can generate antibody titers in people — the FDA anticipates that it will be able to make favorable benefit–risk findings for adults over the age of 65 years and for all persons above the age of 6 months with one or more risk factors that put them at high risk for severe Covid-19 outcomes, as described by the CDC (Figure 2). For all healthy persons — those with no risk factors for severe Covid-19 — between the ages of 6 months and 64 years, the FDA anticipates the need for randomized, controlled trial data evaluating clinical outcomes before Biologics License Applications can be granted. Insofar as possible, when approving a Covid-19 vaccine for high-risk groups, the FDA will encourage manufacturers to conduct randomized, controlled trials in the population of healthy adults as part of their postmarketing commitment (NEJM).